Related Experiment Video
Updated: Oct 18, 2025
02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
930
Management of Priapism: 2021 Update
Christian Ericson1, Bryce Baird1, Gregory A Broderick1
1Department of Urology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
The Urologic Clinics of North America
|October 4, 2021
Summary
Priapism, a persistent erection lasting over 4 hours, is a rare urologic emergency. Prompt diagnosis and intervention are crucial to prevent irreversible erectile tissue damage, especially in ischemic priapism cases.
Area of Science:
- Urology
- Mens Health
Background:
- Priapism is defined as a persistent penile erection lasting more than 4 hours.
- It is a rare condition requiring prompt evaluation and diagnosis.
- Priapism presents with two main pathophysiologic subtypes: ischemic and nonischemic.
Purpose of the Study:
- To highlight current guidelines on priapism management.
- To review contemporary literature on priapism diagnosis and treatment.
- To emphasize the urgency of intervention in ischemic priapism.
Main Methods:
- Review of current clinical guidelines.
- Analysis of contemporary medical literature.
- Focus on pathophysiologic subtypes and emergency interventions.
Main Results:
- Ischemic priapism constitutes the majority of reported cases.
- Ischemic priapism is a urologic emergency demanding immediate intervention.
- Timely intervention is essential to prevent irreversible damage to erectile tissues.
Conclusions:
- Priapism necessitates prompt medical evaluation and diagnosis.
- Ischemic priapism requires urgent intervention to preserve erectile function.
- Understanding subtypes is key for effective priapism management.
More Related Videos
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
278
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
278
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
284
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
284
01:26Angina IV: Management
51
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
51
01:14Myocarditis III: Medical Management
31
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
01:17Pericarditis III: Medical Management
62
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
62
01:20Disorders of the Male Reproductive System
2.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
2.6K